Deep-pocketed investors have adopted a bullish approach towards Bristol-Myers Squibb (NYSE:BMY), and it’s something market players shouldn’t ignore. Our tracking of public options records at Benzinga …
Decoding Bristol-Myers Squibb’s Options Activity: What’s the Big Picture?
view original post